Journal profile · MEDICINE, GENERAL & INTERNAL

Revista de Investigacion Clinica-Clinical and Translational Investigation

ISSN 2385-3956 · INST NACIONAL NUTRICION · MEXICO

Revista de Investigacion Clinica-Clinical and Translational Investigation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.98; hybrid open access; review about 16 weeks (community reports); 49 articles a year; indexed in SCIE and Scopus.

Impact factor1.98Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 16 weeksCommunity average
APC—No source gives fee information
Acceptance—No reports yet
Articles per year49LetPub annual count

Scope

Aims, scope and focus

publishes original clinical and biomedical research of interest to physicians in internal medicine, surgery, and any of their specialties

From the journal's Aims & Scope

Research area (LetPub): MEDICINE, GENERAL & INTERNAL

Editor-in-chief Alfredo Ulloa-AguirrePublisher website

Editorial board by country: none in mainland China; most named Mexico 74, United States 18, Canada 2, Spain 1, Argentina 1 (96 members with a country) Editorial board ↗Publisher website ·

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, General & InternalZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, General & InternalZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, General & InternalZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEDOAJPublisher website

Other: EBSCO, Latindex, Clarivate’s Journal Citation ReportsTM 2023, SCRM Conacyt, Latindex (Catalogue and Directory), Artemisa, Imbiomed, EBSCO EssentialsTM, MIAR

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.98LetPub ·
Impact factor (publisher)
1.5Publisher website ·
CiteScore 2026-06
3.3LetPub ·
SJR 2026-06
0.49LetPub ·
SNIP 2026-06
0.27LetPub ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
76.64%LetPub ·

Volume

Articles per year
49LetPub ·

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 16 weeksLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

Other charges and waivers (author guidelines)

Colour charges
No colour charges
Other fees
No other fees
Page charges
No page charges
Submission fee
No submission fee

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare3 items from the author guidelines
Abstract
≤ 200 words
Manuscript length
≤ 4,000 words
Not considered
case reports
Publisher website · model-extracted, each line checked against the text
Article types accepted10, with length limits
  1. brief communicationat may have a major impact in medicine. Brief Communications are limited to 4,000 words, including the abstract, introduction, materials and methodmain text ≤ 4,000 words
  2. brief communicationsTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  3. brief reviewsTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  4. commentariesTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  5. in-depth reviewIn-Depth Review :Length not stated
  6. in-depth reviewsTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  7. letters to the editorTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  8. original articlesTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  9. perspectivesTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
  10. research lettersTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
Publisher website
Policy excerpts from the journal's websiteOpen access
Open access

Open access, immediate and permanent free access for everyone Model summary

All articles published are open access and can be immediately and permanently free for everyone to read and download.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
INST NACIONAL NUTRICION
Country or region
MEXICO
Language
Multi-Language
ISSN
2385-3956
Society / sponsor
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Official links

FAQ

Frequently asked questions about Revista de Investigacion Clinica-Clinical and Translational Investigation

What CAS zone is Revista de Investigacion Clinica-Clinical and Translational Investigation in?

In the 2025 upgraded edition of the CAS Journal Ranking, Revista de Investigacion Clinica-Clinical and Translational Investigation is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Revista de Investigacion Clinica-Clinical and Translational Investigation?

The latest impact factor listed by LetPub is 1.98; CiteScore 3.3.

How long does peer review take at Revista de Investigacion Clinica-Clinical and Translational Investigation?

Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Revista de Investigacion Clinica-Clinical and Translational Investigation?

According to the journal's author guidelines: Abstract: ≤ 200 words; Manuscript length: ≤ 4,000 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Revista de Investigacion Clinica-Clinical and Translational Investigation based?

Of the 96 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Mexico (74), United States (18) and Canada (2). Counted from the institutions listed on the board page; for reference only.

Which databases index Revista de Investigacion Clinica-Clinical and Translational Investigation?

According to LetPub and DOAJ records, Revista de Investigacion Clinica-Clinical and Translational Investigation is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and DOAJ; that list has not been checked against each database.

Is Revista de Investigacion Clinica-Clinical and Translational Investigation open access, and what is the APC?

Revista de Investigacion Clinica-Clinical and Translational Investigation is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .